immune checkpoint inhibitors

You have access
The Role of ⁸⁹Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals
Guus A.M.S. van Dongen, Wissam Beaino, Albert D. Windhorst, Gerben J.C. Zwezerijnen, Daniela E. Oprea-Lager, N. Harry Hendrikse, Cornelis van Kuijk, Ronald Boellaard, Marc C. Huisman and Danielle J. Vugts

Journal of Nuclear Medicine April 1, 2021, 62 (4) 438-445; DOI: https://doi.org/10.2967/jnumed.119.239558
You have access
Quantification of PD-L1 Expression with ¹⁸F-BMS-986192 PET/CT in Patients with Advanced-Stage Non–Small Cell Lung Cancer
Marc C. Huisman, Anna-Larissa N. Niemeijer, Albert D. Windhorst, Robert C. Schuit, David Leung, Wendy Hayes, Alex Poot, Idris Bahce, Teodora Radonic, Daniela E. Oprea-Lager, Otto S. Hoekstra, Erik Thunnissen, N. Harry Hendrikse, Egbert F. Smit, Adrianus J. de Langen and Ronald Boellaard

Journal of Nuclear Medicine October 1, 2020, 61 (10) 1455-1460; DOI: https://doi.org/10.2967/jnumed.119.240895
You have access
Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma
Jaeyeon Choi, Wissam Beaino, Ronald J. Fecek, Kellsye P.L. Fabian, Charles M. Laymon, Brenda F. Kurland, Walter J. Storkus and Carolyn J. Anderson

Journal of Nuclear Medicine December 1, 2018, 59 (12) 1843-1849; DOI: https://doi.org/10.2967/jnumed.118.209510
You have access
Imaging of Programmed Cell Death Ligand 1: Impact of Protein Concentration on Distribution of Anti-PD-L1 SPECT Agents in an Immunocompetent Murine Model of Melanoma
Jessie R. Nedrow, Anders Josefsson, Sunju Park, Sagar Ranka, Sanchita Roy and George Sgouros

Journal of Nuclear Medicine October 1, 2017, 58 (10) 1560-1566; DOI: https://doi.org/10.2967/jnumed.117.193268

Main menu

User menu

Search

immune checkpoint inhibitors